CLINICAL_TRIALS
trial_result
· 2026-01-28
Clinical Trial Update: A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA [Phase 2]
Summary
Phase 2 proof-of-concept trial of QUC398 for knee osteoarthritis was terminated, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Osteoarthritis, Knee | Phase 2 | Status: TERMINATED | Results posted: 2026-01-28